Pelive Floor Myofascisl Therapy is Associated with Improved VAS Pain Scores and FSFI Scores in Women with Dyspareunia 6 Months Post-partum

Abstract

The incidence of dyspareunia at 6 months post-partum is very high. However, effective treatments are limited. Pelvic floor myofascial therapy is a useful method, we investigated the efficacy of it. 72 post-partum women with dyspareunia between 6 weeks and 3 months after delivering from July 2018 to June 2020 were researched. 30 received no treatment and 42 underwent 15 min, twice a week, totally 3 weeks. The scores of FSFI and VAS pain were completed at enrollment and at 6 months. In the observation group, the VAS score had no significant difference at 6 months, but there was a higher FSFI score at 6 months (17.0, IQR 15.3–18.0 vs. 18.4, IQR 15.8–19.9, p = 0.06). But for the treatment group, at the time of 6 moths, VAS scores were significantly lower and FSFI scores were significantly higher (2.0, IQR 1.5–2.8 vs. 7.3, IQR 6.0–8.4, p < .0001 and 20.4, IQR 18.1–21.8 vs. 18.4, IQR 15.8–19.9, p < .01). So pelvic floor myofascisl improves pelvic floor muscle function, exercise appears to have positive effects on female sexual function.